# Efficacy and mechanisms of vagus nerve stimulation in irritable bowel syndrome: a comprehensive literature review

**Authors:** Yiwen Quan, Tao Zhou

PMC · DOI: 10.3389/fimmu.2026.1769070 · Frontiers in Immunology · 2026-03-11

## TL;DR

Vagus nerve stimulation (VNS) is a promising new treatment for irritable bowel syndrome (IBS) that reduces inflammation, improves gut health, and enhances quality of life.

## Contribution

This review systematically summarizes the mechanisms and clinical outcomes of VNS in IBS, highlighting its multifaceted therapeutic effects.

## Key findings

- VNS reduces inflammation via α7 nicotinic acetylcholine receptor-mediated suppression of TNF-α.
- VNS improves gut microbiota diversity and intestinal barrier integrity in IBS patients.
- Clinical studies show VNS increases bowel movements and reduces pain and symptom scores in IBS patients.

## Abstract

Irritable bowel syndrome (IBS) is a common non-organic functional gastrointestinal disorder. Recently, vagus nerve stimulation (VNS) has been a novel therapeutic strategy for the treatment of IBS. This review provided an overview of the mechanisms of VNS in IBS and clinical applications. Studies about VNS in the treatment of IBS were systematically retrieved from PubMed, EMbase and CNKI databases. Mechanically, pre-clinical evidence highlights VNS as a multifaceted therapy for IBS, including reducing inflammation via α7 nicotinic acetylcholine receptor-mediated suppression of TNF-α, alleviating visceral hypersensitivity, increasing colorectal distension thresholds, enhancing motility through M3 receptor activation and gastric emptying, restoring gut microbiota diversity via elevating bifidobacterium abundance and short-chain fatty acids, and improving intestinal barrier integrity. Consistent with its mechanism, the reduced inflammation biomarkers, improved metabolism content, increased genus bifidobacterium, and improved intestinal barrier integrity are confirmed in clinical patients with IBS after VNS therapy. Besides, clinical studies reveal that VNS can increase the complete spontaneous bowel movements per week, decrease the visual analog scale for abdominal pain and IBS symptom score, improve rectoanal inhibitory reflex, rectal sensation, and improve sustained quality of life. In summary, noninvasive VNS is an effective and novel therapy option for patients with IBS, and its integrative effects are multi-factorial.

## Linked entities

- **Proteins:** TNF (tumor necrosis factor)
- **Diseases:** irritable bowel syndrome (MONDO:0005052)

## Full-text entities

- **Genes:** CHRNA7 (cholinergic receptor nicotinic alpha 7 subunit) [NCBI Gene 1139] {aka CHRNA7-2, NACHRA7, a7nAChR, nAChR7}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** gastrointestinal disorder (MESH:D005767), IBS (MESH:D043183), abdominal pain (MESH:D015746), visceral hypersensitivity (MESH:D004342), inflammation (MESH:D007249)
- **Chemicals:** short-chain fatty acids (MESH:D005232)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13013011/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13013011/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC13013011/full.md

---
Source: https://tomesphere.com/paper/PMC13013011